NYSE:NRZ - New Residential Investment Stock Price, Forecast & News

New Residential Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "NRZ."

New Residential Investment declared a quarterly dividend on Monday, December 16th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.50 per share on Friday, January 31st. This represents a $2.00 dividend on an annualized basis and a yield of 11.64%. The ex-dividend date is Monday, December 30th. View New Residential Investment's Dividend History.

New Residential Investment Corp (NYSE:NRZ) released its quarterly earnings results on Thursday, February, 6th. The real estate investment trust reported $0.61 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.52 by $0.09. The real estate investment trust earned $216.08 million during the quarter, compared to analyst estimates of $241.88 million. New Residential Investment had a net margin of 31.89% and a return on equity of 17.52%. During the same quarter last year, the company earned $0.58 earnings per share. View New Residential Investment's Earnings History.

New Residential Investment is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for New Residential Investment.

7 analysts have issued 12 month price targets for New Residential Investment's shares. Their forecasts range from $16.00 to $20.00. On average, they anticipate New Residential Investment's share price to reach $18.25 in the next year. This suggests a possible upside of 6.2% from the stock's current price. View Analyst Price Targets for New Residential Investment.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for New Residential Investment in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for New Residential Investment.

Press coverage about NRZ stock has been trending very negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. New Residential Investment earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for New Residential Investment.

New Residential Investment saw a decline in short interest in January. As of January 31st, there was short interest totalling 13,180,000 shares, a decline of 30.7% from the January 15th total of 19,010,000 shares. Based on an average daily volume of 3,480,000 shares, the short-interest ratio is presently 3.8 days. Currently, 3.2% of the shares of the company are sold short. View New Residential Investment's Current Options Chain.

Some companies that are related to New Residential Investment include DIGITAL RLTY TR/SH (DLR), Realty Income (O), Ventas (VTR), Weyerhaeuser (WY), Boston Properties (BXP), Essex Property Trust (ESS), Alexandria Real Estate Equities (ARE), HCP (HCP), Mid-America Apartment Communities (MAA), Sun Communities (SUI), WP Carey (WPC), UDR (UDR), ANNALY CAP MGMT/SH (NLY), Extra Space Storage (EXR) and Duke Realty (DRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other New Residential Investment investors own include AT&T (T), Prospect Capital (PSEC), Energy Transfer LP Unit (ET), Two Harbors Investment (TWO), Chembio Diagnostics (CEMI), ANNALY CAP MGMT/SH (NLY), AGNC Investment (AGNC), Starwood Property Trust (STWD), ARBOR RLTY TR I/SH (ABR) and Ares Capital (ARCC).

New Residential Investment's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (1.87%), UBS Group AG (1.58%), State Street Corp (1.40%), Bank of America Corp DE (1.31%), Geode Capital Management LLC (1.28%) and Credit Suisse AG (1.02%). Company insiders that own New Residential Investment stock include Andrew Sloves, David Saltzman, Michael Nierenberg and Robert Mcginnis. View Institutional Ownership Trends for New Residential Investment.

NRZ stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Bank of America Corp DE, First Trust Advisors LP, Standard Life Aberdeen plc, American Assets Capital Advisers LLC, Bank of Montreal Can, SG Americas Securities LLC and Denali Advisors LLC. View Insider Buying and Selling for New Residential Investment.

NRZ stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, FMR LLC, UBS Group AG, Geode Capital Management LLC, Waratah Capital Advisors Ltd., Capital Square LLC, Janus Henderson Group PLC and Assetmark Inc.. Company insiders that have bought New Residential Investment stock in the last two years include Andrew Sloves, David Saltzman, Michael Nierenberg and Robert Mcginnis. View Insider Buying and Selling for New Residential Investment.

Shares of NRZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NRZ stock can currently be purchased for approximately $17.18.

New Residential Investment has a market capitalization of $7.14 billion and generates $1.77 billion in revenue each year. New Residential Investment employs 2,357 workers across the globe.View Additional Information About New Residential Investment.

The official website for New Residential Investment is http://www.newresi.com/.

New Residential Investment's mailing address is 1345 Avenue of the Americas, New York NY, 10105. The real estate investment trust can be reached via phone at 212-798-3150 or via email at [email protected]